Veltuzumab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Veltuzumab, covering 2016-04-13 to 2021-08-16. Get the full timeline:
Most recent: Clinical Trial Update: Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL [Phase 1, Phase 2]